More on GNBT

- Summary
- Chart
- Profile
- Historical

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GNBT Cash Flow Statement

Click line-items for a historical chart and %
Net loss -860.29K
Depreciation and amortization 194.22K
Minority interest share of loss
Reduction of notes receivable - common stock in exchange for services rendered
Write-off of uncollectible notes receivable - common stock
Write-off of deferred offering costs
Write-off of abandoned patents
Gain on disposal of property and equipment
Loss on extinguishment of debt
Common stock issued as employee compensation
Amortization of options and option modifications as stock compensation
Common stock issued for services rendered 4.5K
Amortization of prepaid services in conjunction with common stock issuance
Non-cash compensation expense 27.34K
Stock options and warrants issued for services rendered
Issuance of warrants as additional exercise right inducement
Preferred stock issued for services rendered
Treasury stock redeemed for non-performance of services
Amortization of deferred debt issuance costs and loan origination fees
Amortization of discount on convertible debentures
Common stock issued for interest on convertible debentures & preferred stock
Interest on short-term advance
Founders' shares transferred for services rendered
Fees in connection with refinancing of debt
Warrant repricing costs
Change in fair value of derivative liabilities -1.07M
Accounts receivable
Miscellaneous receivables
Inventory
Other current assets
Accounts payable and accrued expenses 823.73K
Deferred revenue
Other, net 43.35K
Net Cash Used in Operating Activities -698.03K
Purchase of property and equipment
Proceeds from sale of property and equipment
Costs incurred for patents 0
Change in restricted cash
Proceeds from maturity of short term investments
Purchases of short-term investments
Cash received in conjunction with merger
Advances to Antigen Express, Inc.
Increase in officers' loans receivable
Change in deposits
Change in notes receivable - common stock
Change in due from related parties
Other, net
Net Cash Provided by/(Used in) Investing Activities 0
Proceeds from short-term advance
Repayment of short-term advance
Proceeds from issuance of long-term debt
Repayment of long-term debt
Repayment of obligations under capital lease
Change in due to related parties
Proceeds from exercise of warrants
Proceeds from exercise of stock options 2.95K
Proceeds from minority interest investment
Proceeds from issuance of preferred stock
Redemption of SVR preferred stock
Proceeds from issuance of convertible debentures, net
Payment of costs associated with convertible debentures
Repayments of convertible debentures
Purchase of treasury stock
Proceeds from issuance of common stock, net
Purchase and retirement of common stock
Net Cash Provided by Financing Activities 2.95K
Effect of Exchange Rates on Cash -7.72K
Net (Decrease)/Increase in Cash and Cash Equivalents -702.79K
Cash and Cash Equivalents, Beginning of Period
Cash and Cash Equivalents, End of Period
Interest
Income taxes
Issuance of common stock as satisfaction of accounts payable and accrued expenses
Par value of common stock issued in conjunction with cashless exercise of warrants
Issuance of common stock as interest on convertible preferred stock

Entities mentioned with GNBT

View All Entities